Results 231 to 240 of about 26,474 (270)
Some of the next articles are maybe not open access.
Lack of Evidence of HTLV-I Antibodies in the Finnish Population
Scandinavian Journal of Infectious Diseases, 19895,287 serum samples from 2 different sources in Finland, people possibly at risk and healthy blood donors, were tested for the presence of HTLV-I antibodies. No positive cases were found. The result suggests that this virus is not endemic in Finland. 10 cases gave repeatedly a low positive value in the enzyme immune assay (EIA) test but were confirmed ...
P, Leinikki +5 more
openaire +2 more sources
Neurology, 1992
We tested serum specimens from patients with HAM/TSP and asymptomatic HTLV-I carriers from endemic areas of Japan, Jamaica, Colombia, and Chile for neutralizing antibodies against HTLV-I. The data suggest a trend for neutralizing activity to be found more frequently in the sera from HAM/TSP patients than in sera from asymptomatic carriers.
H, Minagawa +5 more
openaire +2 more sources
We tested serum specimens from patients with HAM/TSP and asymptomatic HTLV-I carriers from endemic areas of Japan, Jamaica, Colombia, and Chile for neutralizing antibodies against HTLV-I. The data suggest a trend for neutralizing activity to be found more frequently in the sera from HAM/TSP patients than in sera from asymptomatic carriers.
H, Minagawa +5 more
openaire +2 more sources
Journal of Neuroimmunology, 1991
We investigated the presence of anti-human T-lymphotropic virus type I (HTLV-I) IgM in sera and cerebrospinal fluid from patients with HTLV-I-associated myelopathy (HAM) by Western blot analysis. Analyses of 36 serum samples revealed that most patients (31/36; 86.1%) had anti-HTLV-I IgM, whereas only four of 23 (17.4%) HTLV-I carriers had it.
K, Nagasato +7 more
openaire +2 more sources
We investigated the presence of anti-human T-lymphotropic virus type I (HTLV-I) IgM in sera and cerebrospinal fluid from patients with HTLV-I-associated myelopathy (HAM) by Western blot analysis. Analyses of 36 serum samples revealed that most patients (31/36; 86.1%) had anti-HTLV-I IgM, whereas only four of 23 (17.4%) HTLV-I carriers had it.
K, Nagasato +7 more
openaire +2 more sources
Annals of Neurology, 1988
High titers of antibody to human T-lymphotropic virus type I (HTLV-I) have been reported in the sera and cerebrospinal fluids of patients with tropical spastic paraparesis. By means of agarose isoelectric focusing and selective immunoblotting, we demonstrated oligoclonal bands of immunoglobulin G antibodies to HTLV-I in the serum and cerebrospinal ...
M, Ceroni +6 more
openaire +2 more sources
High titers of antibody to human T-lymphotropic virus type I (HTLV-I) have been reported in the sera and cerebrospinal fluids of patients with tropical spastic paraparesis. By means of agarose isoelectric focusing and selective immunoblotting, we demonstrated oligoclonal bands of immunoglobulin G antibodies to HTLV-I in the serum and cerebrospinal ...
M, Ceroni +6 more
openaire +2 more sources
HTLV-I Antibodies Associated with Cutaneous T Cell Lymphoma in Denmark
1985The first isolation and characterization of a human retrovirus was done by Gallo and co-workers from patients with aggressive cases of adult T cell leukemia/lymphoma in the United States [15, 16]. This virus, named human T cell leukemia/lymphoma virus (HTLV-I) is a T cell-tropic retrovirus [8, 9], initially found sporadically among United States cases ...
G, Lange Wantzin +2 more
openaire +2 more sources
Polymyositis and HTLV‐I antibodies
Annals of Neurology, 1989D. A. Francis, R. A. C. Hughes
openaire +1 more source
HTLV-I ANTIBODIES IN PAPUA NEW GUINEA
The Lancet, 1988D.V. Babona, G.T. Nurse, AmesW. Kazura
openaire +2 more sources
HTLV-I/II antibodies in French blood donors
The Lancet, 1990J, Coste +3 more
openaire +2 more sources
Antibodies to HTLV-I in Sjögren's syndrome
The Lancet, 1995Xavier Mariette +15 more
openaire +1 more source

